GlaxoSmithKline presents a novel antibody-drug conjugate for the treatment of multiple myeloma Jan. 13, 2014
Galena enrolls first patient in phase II trial of GALE-301 cancer immunotherapy in ovarian cancer Jan. 9, 2014
FDA grants fast track designation to Peregrine's immunotherapy bavituximab for second-line NSCLC Jan. 7, 2014
RSS